Last 12 months
Inside the activity.
0 purchase rows · 78 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 35 |
| Mar 2026 | 0 | 13 |
| Apr 2026 | 0 | 9 |
| May 2026 | 0 | 12 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 11, 2019 Filed Dec 13, 2019 21:05 UTC |
SCHLEIFER LEONARD SDirector · President & CEO
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 81,278 | $0.00 Strike: $372.46 | $0.00 |
DisclosureSEC source: 0001237899-19-000031 · edgardoc.xml · derivative · entry 9 SCHLEIFER LEONARD S · CIK 0001218629 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,278 Underlying: Common Stock · 81,278 shares Expires 2029-12-11 F2 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant. Read SEC document |
| December 11, 2019 Filed Dec 13, 2019 21:06 UTC |
Landry Robert EEVP Finance CFO
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 24,500 | $0.00 Strike: $372.46 | $0.00 |
DisclosureSEC source: 0001237899-19-000033 · edgardoc.xml · derivative · entry 4 Landry Robert E · CIK 0001585160 · EVP Finance CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,500 Underlying: Common Stock · 24,500 shares Expires 2029-12-11 F3 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant. Read SEC document |
| December 11, 2019 Filed Dec 13, 2019 21:06 UTC |
Landry Robert EEVP Finance CFO
|
GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001237899-19-000033 · edgardoc.xml · nonDerivative · entry 2 Landry Robert E · CIK 0001585160 · EVP Finance CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,973 F2 · kind: Award of Restricted Stock under the Amended and Restated 2014 Long-Term Incentive Plan that vests in its entirety on December 11, 2023. Read SEC document |
| December 11, 2019 Filed Dec 13, 2019 21:06 UTC |
Landry Robert EEVP Finance CFO
|
GrantCommon Stock | 2,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001237899-19-000033 · edgardoc.xml · nonDerivative · entry 1 Landry Robert E · CIK 0001585160 · EVP Finance CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,973 F1 · kind: Award of Restricted Stock under the Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 11, 2021 and 50% on December 11, 2023. Read SEC document |
| December 11, 2019 Filed Dec 13, 2019 21:06 UTC |
Van Plew Daniel PEVP & General Mgr Industrial O
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 24,500 | $0.00 Strike: $372.46 | $0.00 |
DisclosureSEC source: 0001237899-19-000032 · edgardoc.xml · derivative · entry 4 Van Plew Daniel P · CIK 0001411984 · EVP & General Mgr Industrial O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,500 Underlying: Common Stock · 24,500 shares Expires 2029-12-11 F3 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant. Read SEC document |
| December 11, 2019 Filed Dec 13, 2019 21:06 UTC |
Van Plew Daniel PEVP & General Mgr Industrial O
|
GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001237899-19-000032 · edgardoc.xml · nonDerivative · entry 2 Van Plew Daniel P · CIK 0001411984 · EVP & General Mgr Industrial O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,251 F2 · kind: Award of Restricted Stock under the Amended and Restated 2014 Long-Term Incentive Plan that vests in its entirety on December 11, 2023. Read SEC document |
| December 11, 2019 Filed Dec 13, 2019 21:06 UTC |
Van Plew Daniel PEVP & General Mgr Industrial O
|
GrantCommon Stock | 2,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001237899-19-000032 · edgardoc.xml · nonDerivative · entry 1 Van Plew Daniel P · CIK 0001411984 · EVP & General Mgr Industrial O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,251 F1 · kind: Award of Restricted Stock under the Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 11, 2021 and 50% on December 11, 2023. Read SEC document |
| December 11, 2019 Filed Dec 13, 2019 21:04 UTC |
McCourt MarionSVP Commercial
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 13,650 | $0.00 Strike: $372.46 | $0.00 |
DisclosureSEC source: 0001237899-19-000030 · edgardoc.xml · derivative · entry 3 McCourt Marion · CIK 0001663758 · SVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,650 Underlying: Common Stock · 13,650 shares Expires 2029-12-11 F2 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant. Read SEC document |
| December 11, 2019 Filed Dec 13, 2019 21:04 UTC |
McCourt MarionSVP Commercial
|
GrantCommon Stock | 1,463 | $0.00 | $0.00 |
DisclosureSEC source: 0001237899-19-000030 · edgardoc.xml · nonDerivative · entry 1 McCourt Marion · CIK 0001663758 · SVP Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,963 F1 · kind: Award of Restricted Stock under the Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 11, 2021 and 50% on December 11, 2023. Read SEC document |
| December 11, 2019 Filed Dec 13, 2019 21:03 UTC |
STAHL NEILEVP Research and Development
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 24,500 | $0.00 Strike: $372.46 | $0.00 |
DisclosureSEC source: 0001237899-19-000029 · edgardoc.xml · derivative · entry 5 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,500 Underlying: Common Stock · 24,500 shares Expires 2029-12-11 F2 · derivative.exercise_date: The stock option award vests in four equal annual installments, commencing one year after the date of grant. Read SEC document |
| December 11, 2019 Filed Dec 13, 2019 21:03 UTC |
STAHL NEILEVP Research and Development
|
GrantCommon Stock | 2,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001237899-19-000029 · edgardoc.xml · nonDerivative · entry 1 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,380 F1 · kind: Award of Restricted Stock under the Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 11, 2021 and 50% on December 11, 2023. Read SEC document |
| November 27, 2019 Filed Dec 2, 2019 21:03 UTC |
GOLDSTEIN JOSEPH LDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $33.42 | $0.00 |
DisclosureSEC source: 0001237899-19-000027 · edgardoc.xml · derivative · entry 3 GOLDSTEIN JOSEPH L · CIK 0001225474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 1,000 shares Expires 2021-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F2 · derivative.exercise_date: The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. Read SEC document |
| November 27, 2019 Filed Dec 2, 2019 21:03 UTC |
GOLDSTEIN JOSEPH LDirector
|
SaleCommon Stock | 1,000 | $370.00 | $370,000.00 |
DisclosureSEC source: 0001237899-19-000027 · edgardoc.xml · nonDerivative · entry 2 GOLDSTEIN JOSEPH L · CIK 0001225474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,323 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| November 27, 2019 Filed Dec 2, 2019 21:03 UTC |
GOLDSTEIN JOSEPH LDirector
|
Exercise / conversionCommon Stock | 1,000 | $33.42 | $33,420.00 |
DisclosureSEC source: 0001237899-19-000027 · edgardoc.xml · nonDerivative · entry 1 GOLDSTEIN JOSEPH L · CIK 0001225474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,323 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| November 26, 2019 Filed Nov 26, 2019 21:29 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 300 | $365.41 | $109,623.00 |
DisclosureSEC source: 0001237899-19-000025 · edgardoc.xml · nonDerivative · entry 5 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,455 F3 · price: Represents volume-weighted average price of sales of 300 shares of Company stock on November 26, 2019 at prices ranging from $365.26 to $365.55. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 26, 2019 at each separate price. Read SEC document |
| November 26, 2019 Filed Nov 26, 2019 21:29 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 2,284 | $364.20 | $831,832.80 |
DisclosureSEC source: 0001237899-19-000025 · edgardoc.xml · nonDerivative · entry 4 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,755 F2 · price: Represents volume-weighted average price of sales of 2,284 shares of Company stock on November 26, 2019 at prices ranging from $364.00 to $364.40. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 26, 2019 at each separate price. Read SEC document |
| November 26, 2019 Filed Nov 26, 2019 21:29 UTC |
STAHL NEILEVP Research and Development
|
SaleCommon Stock | 1,422 | $363.58 | $517,010.76 |
DisclosureSEC source: 0001237899-19-000025 · edgardoc.xml · nonDerivative · entry 3 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,039 F1 · price: Represents volume-weighted average price of sales of 1,422 shares of Company stock on November 26, 2019 at prices ranging from $363.07 to $363.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 26, 2019 at each separate price. Read SEC document |
| November 26, 2019 Filed Nov 3, 2020 22:22 UTC |
RYAN ARTHUR FDirector
|
GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001237899-20-000046 · edgardoc.xml · nonDerivative · entry 2 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,323 Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 21:29 UTC |
STAHL NEILEVP Research and Development
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $52.03 | $0.00 |
DisclosureSEC source: 0001237899-19-000025 · edgardoc.xml · derivative · entry 8 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,079 Underlying: Common Stock · 10,000 shares Expires 2021-12-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: With respect to 75,000 underlying shares, the option became exercisable on December 31, 2014, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2014. With respect to 48,079 underlying shares (of which 13,079 remain outstanding), the stock option award vested in four equal annual installments, commencing one year after the date of grant. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 21:29 UTC |
STAHL NEILEVP Research and Development
|
Tax withholdingCommon Stock | 5,994 | $362.75 | $2,174,323.50 |
DisclosureSEC source: 0001237899-19-000025 · edgardoc.xml · nonDerivative · entry 2 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,461 Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 21:29 UTC |
STAHL NEILEVP Research and Development
|
Exercise / conversionCommon Stock | 10,000 | $52.03 | $520,300.00 |
DisclosureSEC source: 0001237899-19-000025 · edgardoc.xml · nonDerivative · entry 1 STAHL NEIL · CIK 0001226689 · EVP Research and Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 21:02 UTC |
VAGELOS P ROYDirector · Chairman of the Board
|
SaleCommon Stock | 4,517 | $366.63 | $1,656,067.71 |
DisclosureSEC source: 0001237899-19-000024 · edgardoc.xml · nonDerivative · entry 15 VAGELOS P ROY · CIK 0001013064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,485 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F10 · price: Represents volume-weighted average price of sales of 4,517 shares of Company stock on November 25, 2019 at prices ranging from $366.07 to $366.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 25, 2019 at each separate price. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 21:02 UTC |
VAGELOS P ROYDirector · Chairman of the Board
|
SaleCommon Stock | 3,269 | $365.25 | $1,194,002.25 |
DisclosureSEC source: 0001237899-19-000024 · edgardoc.xml · nonDerivative · entry 14 VAGELOS P ROY · CIK 0001013064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 309,002 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F9 · price: Represents volume-weighted average price of sales of 3,269 shares of Company stock on November 25, 2019 at prices ranging from $365.02 to $365.71. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 25, 2019 at each separate price. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 21:02 UTC |
VAGELOS P ROYDirector · Chairman of the Board
|
SaleCommon Stock | 3,755 | $364.55 | $1,368,885.25 |
DisclosureSEC source: 0001237899-19-000024 · edgardoc.xml · nonDerivative · entry 13 VAGELOS P ROY · CIK 0001013064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 312,271 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F8 · price: Represents volume-weighted average price of sales of 3,755 shares of Company stock on November 25, 2019 at prices ranging from $364.04 to $364.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 25, 2019 at each separate price. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 21:02 UTC |
VAGELOS P ROYDirector · Chairman of the Board
|
SaleCommon Stock | 3,605 | $363.53 | $1,310,525.65 |
DisclosureSEC source: 0001237899-19-000024 · edgardoc.xml · nonDerivative · entry 12 VAGELOS P ROY · CIK 0001013064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 316,026 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F7 · price: Represents volume-weighted average price of sales of 3,605 shares of Company stock on November 25, 2019 at prices ranging from $363.00 to $363.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 25, 2019 at each separate price. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 21:02 UTC |
VAGELOS P ROYDirector · Chairman of the Board
|
SaleCommon Stock | 2,284 | $362.61 | $828,201.24 |
DisclosureSEC source: 0001237899-19-000024 · edgardoc.xml · nonDerivative · entry 11 VAGELOS P ROY · CIK 0001013064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 319,631 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F6 · price: Represents volume-weighted average price of sales of 2,284 shares of Company stock on November 25, 2019 at prices ranging from $362.02 to $362.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 25, 2019 at each separate price. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 21:02 UTC |
VAGELOS P ROYDirector · Chairman of the Board
|
SaleCommon Stock | 2,492 | $361.46 | $900,758.32 |
DisclosureSEC source: 0001237899-19-000024 · edgardoc.xml · nonDerivative · entry 10 VAGELOS P ROY · CIK 0001013064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 321,915 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F5 · price: Represents volume-weighted average price of sales of 2,492 shares of Company stock on November 25, 2019 at prices ranging from $361.06 to $361.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 25, 2019 at each separate price. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 21:02 UTC |
VAGELOS P ROYDirector · Chairman of the Board
|
SaleCommon Stock | 592 | $360.37 | $213,339.04 |
DisclosureSEC source: 0001237899-19-000024 · edgardoc.xml · nonDerivative · entry 9 VAGELOS P ROY · CIK 0001013064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 324,407 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F4 · price: Represents volume-weighted average price of sales of 592 shares of Company stock on November 25, 2019 at prices ranging from $360.01 to $360.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 25, 2019 at each separate price. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 21:02 UTC |
VAGELOS P ROYDirector · Chairman of the Board
|
SaleCommon Stock | 1,479 | $359.46 | $531,641.34 |
DisclosureSEC source: 0001237899-19-000024 · edgardoc.xml · nonDerivative · entry 8 VAGELOS P ROY · CIK 0001013064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 324,999 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F3 · price: Represents volume-weighted average price of sales of 1,479 shares of Company stock on November 25, 2019 at prices ranging from $359.05 to $359.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 25, 2019 at each separate price. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 21:02 UTC |
VAGELOS P ROYDirector · Chairman of the Board
|
SaleCommon Stock | 156 | $358.92 | $55,991.52 |
DisclosureSEC source: 0001237899-19-000024 · edgardoc.xml · nonDerivative · entry 7 VAGELOS P ROY · CIK 0001013064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 326,478 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F2 · price: Represents volume-weighted average price of sales of 156 shares of Company stock on November 25, 2019 at prices ranging from $358.68 to $358.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 25, 2019 at each separate price. Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 21:02 UTC |
VAGELOS P ROYDirector · Chairman of the Board
|
GiftCommon Stock | 22,093 | $0.00 | $0.00 |
DisclosureSEC source: 0001237899-19-000024 · edgardoc.xml · nonDerivative · entry 6 VAGELOS P ROY · CIK 0001013064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 326,634 Read SEC document |
| November 22, 2019 Filed Nov 22, 2019 21:07 UTC |
GOLDSTEIN JOSEPH LDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $33.42 | $0.00 |
DisclosureSEC source: 0001237899-19-000020 · edgardoc.xml · derivative · entry 6 GOLDSTEIN JOSEPH L · CIK 0001225474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 1,000 shares Expires 2021-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F2 · derivative.exercise_date: The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. Read SEC document |
| November 22, 2019 Filed Nov 22, 2019 21:07 UTC |
GOLDSTEIN JOSEPH LDirector
|
SaleCommon Stock | 1,000 | $360.00 | $360,000.00 |
DisclosureSEC source: 0001237899-19-000020 · edgardoc.xml · nonDerivative · entry 4 GOLDSTEIN JOSEPH L · CIK 0001225474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,323 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| November 22, 2019 Filed Nov 22, 2019 21:07 UTC |
GOLDSTEIN JOSEPH LDirector
|
Exercise / conversionCommon Stock | 1,000 | $33.42 | $33,420.00 |
DisclosureSEC source: 0001237899-19-000020 · edgardoc.xml · nonDerivative · entry 3 GOLDSTEIN JOSEPH L · CIK 0001225474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,323 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| November 22, 2019 Filed Nov 26, 2019 21:02 UTC |
VAGELOS P ROYDirector · Chairman of the Board
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 46,138 | $0.00 Strike: $21.25 | $0.00 |
DisclosureSEC source: 0001237899-19-000024 · edgardoc.xml · derivative · entry 21 VAGELOS P ROY · CIK 0001013064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,655 Underlying: Common Stock · 46,138 shares Expires 2019-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F12 · derivative.exercise_date: The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant. Read SEC document |
| November 22, 2019 Filed Nov 26, 2019 21:02 UTC |
VAGELOS P ROYDirector · Chairman of the Board
|
GiftCommon Stock | 14,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001237899-19-000024 · edgardoc.xml · nonDerivative · entry 5 VAGELOS P ROY · CIK 0001013064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 348,727 Read SEC document |
| November 22, 2019 Filed Nov 26, 2019 21:02 UTC |
VAGELOS P ROYDirector · Chairman of the Board
|
Tax withholdingCommon Stock | 23,989 | $358.33 | $8,595,978.37 |
DisclosureSEC source: 0001237899-19-000024 · edgardoc.xml · nonDerivative · entry 4 VAGELOS P ROY · CIK 0001013064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362,727 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| November 22, 2019 Filed Nov 26, 2019 21:02 UTC |
VAGELOS P ROYDirector · Chairman of the Board
|
Exercise / conversionCommon Stock | 46,138 | $21.25 | $980,432.50 |
DisclosureSEC source: 0001237899-19-000024 · edgardoc.xml · nonDerivative · entry 3 VAGELOS P ROY · CIK 0001013064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 386,716 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| November 22, 2019 Filed Nov 3, 2020 22:22 UTC |
RYAN ARTHUR FDirector
|
GiftCommon Stock | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001237899-20-000046 · edgardoc.xml · nonDerivative · entry 1 RYAN ARTHUR F · CIK 0001187443 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,323 Read SEC document |
| November 21, 2019 Filed Nov 22, 2019 21:07 UTC |
GOLDSTEIN JOSEPH LDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $33.42 | $0.00 |
DisclosureSEC source: 0001237899-19-000020 · edgardoc.xml · derivative · entry 5 GOLDSTEIN JOSEPH L · CIK 0001225474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 1,000 shares Expires 2021-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F2 · derivative.exercise_date: The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. Read SEC document |
| November 21, 2019 Filed Nov 22, 2019 21:07 UTC |
GOLDSTEIN JOSEPH LDirector
|
SaleCommon Stock | 1,000 | $350.00 | $350,000.00 |
DisclosureSEC source: 0001237899-19-000020 · edgardoc.xml · nonDerivative · entry 2 GOLDSTEIN JOSEPH L · CIK 0001225474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,323 F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| November 21, 2019 Filed Nov 22, 2019 21:07 UTC |
GOLDSTEIN JOSEPH LDirector
|
Exercise / conversionCommon Stock | 1,000 | $33.42 | $33,420.00 |
DisclosureSEC source: 0001237899-19-000020 · edgardoc.xml · nonDerivative · entry 1 GOLDSTEIN JOSEPH L · CIK 0001225474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,323 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Read SEC document |
| November 21, 2019 Filed Nov 26, 2019 21:02 UTC |
VAGELOS P ROYDirector · Chairman of the Board
|
GiftCommon Stock | 7,246 | $0.00 | $0.00 |
DisclosureSEC source: 0001237899-19-000024 · edgardoc.xml · nonDerivative · entry 2 VAGELOS P ROY · CIK 0001013064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,578 Read SEC document |
| November 18, 2019 Filed Dec 13, 2019 21:44 UTC |
YANCOPOULOS GEORGEDirector · President and CSO
|
GiftClass A Stock · Derivative | 23,367 | $0.00 | $0.00 |
DisclosureSEC source: 0000930413-19-003028 · ownership.xml · derivative · entry 16 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and CSO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 0 Underlying: Common Stock · 23,367 shares Expires not disclosed F2 · derivative.exercise_price: Class A Stock of Regeneron Pharmaceuticals, Inc. ("Regeneron") converts to Common Stock of Regeneron on a one-to-one basis upon certain events or upon election of the shareholder. F3 · derivative.exercise_date: These shares of Class A Stock are presently convertible and such conversion feature does not expire. F3 · derivative.expiration_date: These shares of Class A Stock are presently convertible and such conversion feature does not expire. Read SEC document |
| November 18, 2019 Filed Dec 13, 2019 21:44 UTC |
YANCOPOULOS GEORGEDirector · President and CSO
|
GiftClass A Stock · Derivative | 23,367 | $0.00 | $0.00 |
DisclosureSEC source: 0000930413-19-003028 · ownership.xml · derivative · entry 15 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,367 Underlying: Common Stock · 23,367 shares Expires not disclosed F2 · derivative.exercise_price: Class A Stock of Regeneron Pharmaceuticals, Inc. ("Regeneron") converts to Common Stock of Regeneron on a one-to-one basis upon certain events or upon election of the shareholder. F3 · derivative.exercise_date: These shares of Class A Stock are presently convertible and such conversion feature does not expire. F3 · derivative.expiration_date: These shares of Class A Stock are presently convertible and such conversion feature does not expire. Read SEC document |
| November 18, 2019 Filed Dec 13, 2019 21:44 UTC |
YANCOPOULOS GEORGEDirector · President and CSO
|
GiftCommon Stock | 325,986 | $0.00 | $0.00 |
DisclosureSEC source: 0000930413-19-003028 · ownership.xml · nonDerivative · entry 13 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and CSO 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 0 Read SEC document |
| November 18, 2019 Filed Dec 13, 2019 21:44 UTC |
YANCOPOULOS GEORGEDirector · President and CSO
|
GiftCommon Stock | 325,986 | $0.00 | $0.00 |
DisclosureSEC source: 0000930413-19-003028 · ownership.xml · nonDerivative · entry 1 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 325,986 Read SEC document |
| November 14, 2019 Filed Nov 26, 2019 21:02 UTC |
VAGELOS P ROYDirector · Chairman of the Board
|
GiftCommon Stock | 40,681 | $0.00 | $0.00 |
DisclosureSEC source: 0001237899-19-000024 · edgardoc.xml · nonDerivative · entry 1 VAGELOS P ROY · CIK 0001013064 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 347,824 Read SEC document |
| November 14, 2019 Filed Dec 13, 2019 21:44 UTC |
YANCOPOULOS GEORGEDirector · President and CSO
|
GiftCommon Stock | 2,366 | $0.00 | $0.00 |
DisclosureSEC source: 0000930413-19-003028 · ownership.xml · nonDerivative · entry 12 YANCOPOULOS GEORGE · CIK 0001226690 · Director · President and CSO 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 325,989 Read SEC document |
| November 12, 2019 Filed Nov 13, 2019 21:11 UTC |
BROWN MICHAEL SDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 4,500 | $0.00 Strike: $273.67 | $0.00 |
DisclosureSEC source: 0001708138-19-000012 · edgardoc.xml · derivative · entry 5 BROWN MICHAEL S · CIK 0001174475 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Underlying: Common Stock · 4,500 shares Expires 2024-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). F3 · derivative.exercise_date: The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.